Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
Read Article
News
2024
2023
Archive
Search news articles
August 21, 2019
Cidara Therapeutics to Present Data From its Cloudbreak Antiviral Program at the Options X for the Control of Influenza Conference
August 7, 2019
Vor Biopharma Appoints Veteran Biotech Executive Dr. Robert Ang as President and Chief Executive Officer
August 6, 2019
Cleave Therapeutics Appoints Amy Burroughs Chief Executive Officer and Completes $12 Million Equity Financing
August 5, 2019
Aprea Therapeutics Appoints Scott Coiante as Chief Financial Officer
July 31, 2019
Vor Biopharma Appoints Dr. Bill Lundberg to its Board of Directors
July 29, 2019
Arvinas Appoints Ronald Peck, M.D. as Chief Medical Officer
July 29, 2019
Cidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal Rezafungin
July 25, 2019
Arvinas Strengthens Board of Directors with Addition of Leslie Norwalk
July 19, 2019
Arvinas to Present Preclinical Tau-Directed PROTAC® Protein Degrader Data at Alzheimer’s Association International Conference
July 19, 2019
Pear Therapeutics Announces FDA Submission for SOMRYST™, a Prescription Digital Therapeutic for the Treatment of Adults with Chronic Insomnia and Depression
« Previous Page
1
…
65
66
67
68
69
…
119
Next Page »